ERBB2 and breast cancer: As seen in HR + HER2-BC, the invasive size (OR 5.437, 95% CI 1.429–20.690) and TIL level (OR 0.977, 95% CI 0.961–0.993) significantly predicted a high and low Emax in HER2 + BC.